Clinical Trial Update: Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on treating moderate ischemic mitral regurgitation in patients with coronary artery disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Mitral Regurgitation

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Artery Disease, Ischemic Mitral Regurgitation | Phase 4 | Status: RECRUITING